Workflow
云南白药(000538) - 2024年7月1日调研活动附件之投资者调研会议记录(二)
YUNNAN BAIYAOYUNNAN BAIYAO(SZ:000538)2024-07-03 09:53

Sales Performance and Marketing Strategies - In 2023, Yunnan Baiyao toothpaste held a domestic market share of 24.60%, maintaining the top position in the market [2] - During the "Double 11" shopping festival, the health product division achieved multiple first-place rankings, with the Yunnan Baiyao Tmall flagship store surpassing 100 million in sales for the first time [2] - Over 1.47 million offline promotional activities were conducted, covering 1,465 cities [2] Financial Performance - The health product division reported a revenue of 6.422 billion yuan in 2023, reflecting a year-on-year growth of 6.50% [3] - The provincial pharmaceutical company achieved a revenue of 24.49 billion yuan in 2023, with a year-on-year increase of 5.63% [4] Operational Efficiency - The provincial pharmaceutical company improved its overall operational efficiency, with a 7.4% increase in order fulfillment rate and a 22% enhancement in order response speed [4] - The company implemented a refined service system, offering delivery options such as same-day and next-day delivery [4] Research and Development Plans - The company focuses on short-term, mid-term, and long-term R&D projects, emphasizing market-driven innovation and evidence-based medicine [5] - Short-term goals include secondary innovation of existing products and rapid development of drug-device combinations [5] - Long-term strategies involve the development of innovative drugs, particularly in traditional Chinese medicine and nuclear medicine [5]